The 10 commandments of troponin, with special reference to high sensitivity assays

Heart

Volumn 97, Issue 11, 2011, Pages 940-946

  Jaffe, Allan S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATINE KINASE MB; DOXORUBICIN; TRASTUZUMAB; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CORONARY ARTERY BYPASS SURGERY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EMERGENCY WARD; EXERCISE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HOSPITAL LABORATORY; HUMAN; KIDNEY FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

ANGIOPLASTY; CRITICAL ILLNESS; DECISION MAKING; DIAGNOSIS, DIFFERENTIAL; DRUG TOXICITY; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL INFARCTION; PROFESSIONAL PRACTICE; RESPIRATORY INSUFFICIENCY; TROPONIN;

EID: 79955881524     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.185751     Document Type: Review

References (24)

1. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55:1303-6.
2. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525e38. Index guideline document for the diagnosis of AMI.
3. Apple FS, Jesse RL, Newby LK, et al. National Academy of Clinical Biochemistry and IFCC committee on standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 2007;53:547-51. (Pubitemid 46580222)
4. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry practice guidelines: clinical characteristics and utilization of biomarkers in acute coronary syndromes. Clin Chem 2007;53:552-74.
5. Panteghini M, Gerhardt W, Apple FS, et al. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:174-8.
6. Wu AH, Jaffe AS. The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing. Am Heart J 2008;155:208-14. An excellent review of some of the problems associated with high sensitivity assays, including both analytical and clinical caveats.
7. Bais R. The effect of sample hemolysis on cardiac troponin I and T assays. Clin Chem 2010;56:1357-9.
8. Diamond GA, Kaul S. How would the Reverend Bayes interpret high-sensitivity troponin? Circulation 2010;121:1172-5. A particularly important article about the need to include Baysian thinking when using high sensitivity troponin assays.
9. Assomull RG, Lyne JC, Keenan N, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J 2007;28:1242-9. An excellent paper evaluating patients with chest pain, possible AMI and normal coronary arteries with MRI.
10. MacRae AR, Kavsak PA, Lustig V, et al. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006;52:812-18. (Pubitemid 43673258)
11. Eggers KM, Oldgren J, Nordenskjold A, et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574e81.
12. Wallace TW, Abdullah SM, Drazner MH, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113:1958-65. Data from a large cohort of putatively stable outpatients documenting a 0.7% incidence of elevated cTnT related to cardiovascular comorbidities.
13. Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving none ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010;56:642-50.
14. Katus HA, Giannitsis E, Jaffe AS, et al. Higher sensitivity troponin assays: quo vadis? Eur Heart J 2009;30:127-8. An editorial pointing out many of the problems of high sensitivity assays and urging a slow progression towards their use.
15. Vasile VC, Chai HS, Khambatta S, et al. Significance of elevated cardiac troponin T levels in critically ill patients with acute respiratory disease. Am J Cardiol 2010;123:1049-58.
16. Mehta NJ, Khan IA, Gupta V, et al. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004;95:13-17. (Pubitemid 38670466)
17. Vasile VC, Babuin L, Rio Perez JA, et al. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med 2009;37:140-7.
18. Landesberg G, Beattie S, Mosseri M, et al. Perioperative myocardial infarction. Circulation 2009;119:2936-44. An excellent review of the problems associated with perioperative AMI which are for the most part so called type 2 AMIs.
19. Wu AHB, Jaffe AS, Apple FS, et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure. Clin Chem 2007;53:2086-96. (Pubitemid 350197291)
20. Prasad A, Rihal CS, Lennon RJ, et al. Significance of periprocedural myonecrosis on outcomes following percutaneous coronary intervention. Circ Cardiovasc Interv 2008;1:10-19. The only paper that uses the 99th centile value as the baseline value in its analysis, which is key to the proper interpretation of post-PCI biomarker elevations.
21. Cardinale D, Colombo A, Sandri MT, et al. Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 2006;114:2474-81. Beautiful work detailing the ability of ACE inhibitors to reduce the frequency of cTnI elevations and, with that, the subsequent diminution of left ventricular performance.
22. Cardinale D, Colombo A, Torrisi R, et al. Trastuzumab-induced cardiotoxicity: clinical and prognostic implications of troponin I evaluation. J Clin Oncol 2010;28:3910-16.
23. Henry CR, Satran D, Lindgren B, et al. Myocardial injury and long-term mortality following moderate to severe carbon monoxide poisoning. JAMA 2006;295:398-402. An important paper documenting elevated cTn values in patients with carbon monoxide poisoning and its prognostic significance.
24. Mingels A, Jacobs L, Michielsen E, et al. Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays. Clin Chem 2009;55:101-8.